GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuraxis Inc (AMEX:NRXS) » Definitions » Days Payable

NRXS (Neuraxis) Days Payable : 677.42 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neuraxis Days Payable?

Neuraxis's average Accounts Payable for the three months ended in Dec. 2024 was $0.78 Mil. Neuraxis's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.11 Mil. Hence, Neuraxis's Days Payable for the three months ended in Dec. 2024 was 677.42.

The historical rank and industry rank for Neuraxis's Days Payable or its related term are showing as below:

NRXS' s Days Payable Range Over the Past 10 Years
Min: 125.21   Med: 907.96   Max: 1684.06
Current: 1064.43

During the past 5 years, Neuraxis's highest Days Payable was 1684.06. The lowest was 125.21. And the median was 907.96.

NRXS's Days Payable is ranked better than
85.69% of 706 companies
in the Biotechnology industry
Industry Median: 122.35 vs NRXS: 1064.43

Neuraxis's Days Payable declined from Dec. 2023 (1,122.25) to Dec. 2024 (677.42). It may suggest that Neuraxis accelerated paying its suppliers.


Neuraxis Days Payable Historical Data

The historical data trend for Neuraxis's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuraxis Days Payable Chart

Neuraxis Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Days Payable
125.21 253.62 1,275.66 1,684.06 907.96

Neuraxis Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,122.25 1,484.94 1,451.98 978.35 677.42

Competitive Comparison of Neuraxis's Days Payable

For the Biotechnology subindustry, Neuraxis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuraxis's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuraxis's Days Payable distribution charts can be found below:

* The bar in red indicates where Neuraxis's Days Payable falls into.



Neuraxis Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Neuraxis's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

Days Payable (A: Dec. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2023 ) + Accounts Payable (A: Dec. 2024 )) / count ) / Cost of Goods Sold (A: Dec. 2024 )*Days in Period
=( (1.204 + 0.597) / 2 ) / 0.362*365
=0.9005 / 0.362*365
=907.96

Neuraxis's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

Days Payable (Q: Dec. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2024 ) + Accounts Payable (Q: Dec. 2024 )) / count ) / Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=( (0.962 + 0.597) / 2 ) / 0.105*365 / 4
=0.7795 / 0.105*365 / 4
=677.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuraxis Days Payable Related Terms

Thank you for viewing the detailed overview of Neuraxis's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuraxis Business Description

Traded in Other Exchanges
N/A
Address
11611 N. Meridian Street, Suite 330, Carmel, IN, USA
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Executives
Masimo Corp 10 percent owner 52 DISCOVERY, IRVINE CA 92618
John G Seale officer: CHIEF FINANCIAL OFFICER 10038 OXFORD PIKE, BROOKVILLE IN 47012
Brian Allen Carrico director, officer: CEO, DIRECTOR 11550 NORTH MERIDIAN STREET, SUITE 325, CARMEL IN 46032
Christopher Robin Brown director, officer: DIRECTOR OF INNOVATION 829 S. ADAMS ST, VERSAILLES IN 47042
Daniel Jerome Clarence officer: CHIEF OPERATING OFFICER 10461 W GRANDVIEW DRIVE, COLUMBUS IN 47201
Thomas Joeseph Carrico officer: CHIEF REGULATORY OFFICER 829 S. ADAMS ST., VERSAILLES IN 47042
Gary Merril Peterson officer: DIR.OF DESIGN & ENGINEERING 829 S. ADAMS ST., VERSAILLES IN 47042
Bradley Mitchell Watkins director 10322 MEDICIS PLACE, WELLINGTON FL 33449
Jane Elizabeth Keyser director 220 VIRGINIA AVENUE, INDIANAPOLIS IN 46204
Timothy Robert Henrichs director 324 LEITCH AVENUE, LA GRANGE IL 60525
Adrian Miranda officer: Chief Medical Officer, SVP 829 S. ADAMS STREET, VERSAILLES IN 47042